153 related articles for article (PubMed ID: 24977006)
1. Prognostic value of FGFR1 gene copy number in patients with non-small cell lung cancer: a meta-analysis.
Yang W; Yao YW; Zeng JL; Liang WJ; Wang L; Bai CQ; Liu CH; Song Y
J Thorac Dis; 2014 Jun; 6(6):803-9. PubMed ID: 24977006
[TBL] [Abstract][Full Text] [Related]
2. The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data.
Wang Y; Gao W; Xu J; Chen X; Yang Y; Zhu Y; Yin Y; Guo R; Liu P; Shu Y; Liu L
Biomed Res Int; 2015; 2015():763080. PubMed ID: 26788508
[TBL] [Abstract][Full Text] [Related]
3. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
Seo AN; Jin Y; Lee HJ; Sun PL; Kim H; Jheon S; Kim K; Lee CT; Chung JH
Virchows Arch; 2014 Nov; 465(5):547-58. PubMed ID: 25086725
[TBL] [Abstract][Full Text] [Related]
4. FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.
Jiang T; Gao G; Fan G; Li M; Zhou C
Lung Cancer; 2015 Jan; 87(1):1-7. PubMed ID: 25433983
[TBL] [Abstract][Full Text] [Related]
5. The association between fibroblast growth factor receptor 1 gene amplification and lung cancer: a meta-analysis.
Miao JL; Zhou JH; Cai JJ; Liu RJ
Arch Med Sci; 2020; 16(1):16-26. PubMed ID: 32051701
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.
Tran TN; Selinger CI; Kohonen-Corish MRJ; McCaughan BC; Kennedy CW; O'Toole SA; Cooper WA
Lung Cancer; 2013 Sep; 81(3):462-467. PubMed ID: 23806793
[TBL] [Abstract][Full Text] [Related]
7. The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis.
Xie FJ; Lu HY; Zheng QQ; Qin J; Gao Y; Zhang YP; Hu X; Mao WM
Onco Targets Ther; 2016; 9():171-81. PubMed ID: 26793001
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis.
Hu Y; Ai LS; Zhou LQ
PLoS One; 2021; 16(5):e0251202. PubMed ID: 33989301
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis.
Kim JH; Kim HS; Kim BJ
J Cancer; 2018; 9(10):1836-1845. PubMed ID: 29805710
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
[TBL] [Abstract][Full Text] [Related]
11. Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis.
Berghmans T; Paesmans M; Mascaux C; Martin B; Meert AP; Haller A; Lafitte JJ; Sculier JP
Ann Oncol; 2006 Nov; 17(11):1673-6. PubMed ID: 16980598
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer.
Miao JL; Liu RJ; Zhou JH; Meng SH
Chin Med J (Engl); 2016 Dec; 129(23):2868-2872. PubMed ID: 27901003
[TBL] [Abstract][Full Text] [Related]
13. Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.
Toschi L; Finocchiaro G; Nguyen TT; Skokan MC; Giordano L; Gianoncelli L; Perrino M; Siracusano L; Di Tommaso L; Infante M; Alloisio M; Roncalli M; Scorsetti M; Jänne PA; Santoro A; Varella-Garcia M
PLoS One; 2014; 9(4):e95303. PubMed ID: 24736592
[TBL] [Abstract][Full Text] [Related]
14. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma.
Craddock KJ; Ludkovski O; Sykes J; Shepherd FA; Tsao MS
J Thorac Oncol; 2013 Nov; 8(11):1371-7. PubMed ID: 24077455
[TBL] [Abstract][Full Text] [Related]
18. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR.
Gadgeel SM; Chen W; Cote ML; Bollig-Fischer A; Land S; Schwartz AG; Bepler G
PLoS One; 2013; 8(11):e79820. PubMed ID: 24255716
[TBL] [Abstract][Full Text] [Related]
20. The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.
Liu L; Shao X; Gao W; Bai J; Wang R; Huang P; Yin Y; Liu P; Shu Y
J Thorac Oncol; 2010 Dec; 5(12):1922-32. PubMed ID: 21155183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
